DOCSLIB.ORG

NCAA [R] Drug-Testing Program, 1999-2000

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
NCAA [R] Drug-Testing Program, 1999-2000 DOCUMENT RESUME ED 436 990 HE 032 608 AUTHOR Halpin, Ty, Ed. TITLE NCAA[R] Drug-Testing Program, 1999-2000. INSTITUTION National Collegiate Athletic Association, Indianapolis, IN. PUB DATE 1999-00-00 NOTE 15p. AVAILABLE FROM National Collegiate Athletic Association, P.O. Box 6222, Indianapolis, IN 46206-6222. Tel: 317-917-6222. PUB TYPE Legal/Legislative/Regulatory Materials (090) EDRS PRICE MF01/PC01 Plus Postage. DESCRIPTORS Athletes; *College Athletics; Drug Abuse; *Drug Use Testing; Higher Education; Illegal Drug Use IDENTIFIERS *National Collegiate Athletic Association ABSTRACT The drug testing program supports NCAA's goal to protect the health and safety of student-athletes competing for their institutions, while reaffirming the organization's commitment to fair and equitable competition. Proposal Nos. 30 and 52-54 provide a program for the NCAA's members to ensure that no one athlete has a chemically-induced advantage or is pressured to use chemical substances. The program involves urine collection on specific occasions and laboratory analyses for substances on a list of banned drugs including stimulants, anabolic agents such as steroids, diuretics, illegal drugs, or peptide hormones. Consent forms must be signed by student athletes if they wish to participate in NCAA programs. (JM) Reproductions supplied by EDRS are the best that can be made from the original document. 6' 3r; - RUG- ESTING ROGRAI4 1999-2000 , Pso (2 BEST COPY AVAILABLE U.S. DEPARTMENT OF EDUCATION Office of Educational Research and Improvement PERMISSION TO REPRODUCE AND EDUCATIONAL RESOURCES INFORMATION DISSEMINATE THIS MATERIAL HAS CENTER (ERIC) BEEN GRANTED BY his document has been reproduced as received from the person or organization originating it. U.Lt.)L.51-1 Minor changes have been made to improve reproduction quality. TO THE EDUCATIONAL RESOURCES Points of view or opinions stated in this INFORMATION CENTER (ERIC) document do not necessarily represent official OERI position or policy. 1 ij competition may result in the student-athlete's ineligi- -Off OPUTInfinPP@VT@INI bility for participation in all intercollegiate athletics. With their approval of Proposal No. 30 at the The consent form shall be kept on file in the office of January 1986 NCAA Convention and Proposal Nos. the director of athletics, and such file shall be avail- 52 -54 at the January 1990 Convention, NCAA institutions able for examination upon request by an authorized reaffirmed their dedication to the ideal of fair and equi- representative of the NCAA. table competition at their championships and postseason certified events. At the same time, they took another step in Connitution the protection of the health and safety of the student- A nonrecruited student-athlete in sports other than athletes competing therein. So that no one participant those sports involved in the Association's year-round might have an artificially induced advantage, so that no drug-testing program may participate in preseason one participant might be pressured to use chemical sub- practice activities prior to the team's first contest or stances in order to remain competitive, and to safeguard date of competition without signing the drug-testing the health and safety of participants, this NCAA drug- consent form. testing program has been created. The program involves urine collection on specific occasions and laboratory analyses for substances on a list Conotituta©W33.246.2 of banned-drug classes developed by the NCAA Executive In Division III, the consent form shall be administered Committee.* This list consists of substances generally pur- individually to each student-athlete prior to the stu- ported to be performance enhancing and/or potentially dent's participation in intercollegiate competition each harmful to the health and safety of the student-athlete. The academic year. Failure to complete and sign the con- drug classes specifically include stimulants (such as sent form before such competition shall result in the amphetamines and cocaine) and anabolic steroids, as well student-athlete's ineligibility for practice and competi- as other drugs. tion in all intercollegiate athletics. The consent form shall be kept on file in the office of the director of ath- This list was approved initially by the 1986 NCAA Convention. letics, and such file shall be available for examination upon request by an authorized representative of the Onfq=liecanq 11209[1A©rm NCAA. Drug-testing legislation is reported here for ease of reference. Please refer to the NCAA Division I, II or III Biuj Oaku 110.2 Manual for a complete (and division specific) review of A member institution's athletics department staff mem- NCAA drug-testing legislation. bers or others employed by the intercollegiate athletics program who have knowledge of a student-athlete's EonnitutionB.2.11.6 use at any time of a substance on the list of banned drugs, as set forth in 31.2.3.1, shall follow institution- The active member shall administer annually, on a al procedures dealing with drug abuse or shall be form prescribed by the Management Council, a subject to disciplinary or corrective action as set forth signed drug-testing consent form for each student- in 19.6.2.2. athlete (per 12.02.5), pursuant to 14.1.4 and 30.5. 13g0aw !Anima Condututu®w 3.2.k.Ga A student-athlete who is found to have utilized a sub- In Divisions I and II sports in which the Association stance on the list of banned drugs, as set forth in conducts year-round drug testing, the consent form 31.2.3.1, shall be declared ineligible for further par- shall be administered individually to student-athletes ticipation in postseason and regular-season competi- each academic year at the time the intercollegiate tion in accordance with the ineligibility provisions in squad first reports for practice or prior to the Monday 18.4.1.5.1. of the institution's fourth week of classes, whichever date occurs first. In those sports in which the Association does not conduct year-round drug testing, Bgfiamogl.1.33.11 the form shall be administered individually to each Prior to participation in intercollegiate competition student-athlete prior to the institution's first scheduled each academic year, a student-athlete shall sign a intercollegiate competition. Failure to sign the consent statement in a form prescribed by the Management form by the deadline shall result in the student- Council in which the student-athlete submits informa- athlete's ineligibility for practice or competition until tion related to eligibility, recruitment, financial aid, the student-athlete has signed the form. Failure to amateur status, previous positive drug tests admin- complete and sign the form prior to practice or istered by any other athletics organization and 3 1 involvement in organized gambling activities related form must be included on the institution's squad-list to intercollegiate or professional athletics competition form, and any student-athlete who is included on the under the Association's governing legislation. Failure squad-list form must have signed a drug-testing con- to complete and sign the statement shall result in the sent form pursuant to 14.1.4. student-athlete's ineligibility for participation in all intercollegiate competition. Violations of this bylaw do BgElawII kang not affect a student-athlete's eligibility if the violation occurred due to an institutional administrative error or A student-athlete who is found to have utilized a sub- oversight, and the student-athlete subsequently signs stance on the list of banned drugs, as set forth in the form; however, the violation shall be considered 31.2.3.1, shall be declared ineligible for further par- an institutional violation per 2.8.1. ticipation in postseason and regular-season competi- tion in accordance with the ineligibility provisions in 18.4.1.5.1. The certifying institution may appeal to ByllaunkInunl.1 the Academics/Eligibility/Compliance Cabinet for The institution shall promptly notify in writing the restoration of the student-athlete's eligibility if the insti- NCAA's director of sports sciences regarding a tution concludes that circumstances warrant restora- student-athlete's disclosure of a previous positive test tion. for banned substances administered by any other ath- letics organization. Nam ankangau kllas A student-athlete who tests positive (in accordance with the testing methods authorized by the Executive Each academic year a student-athlete shall sign a Committee) shall be charged with the loss of a mini- form prescribed by the Management Council in which mum of one season of competition in all sports if the the student consents to be tested for the use of drugs season of competition has not yet begun for that prohibited by NCAA legislation. Failure to complete student-athlete or a minimum of the equivalent of one and sign the consent form prior to practice or compe- full season of competition in all sports if the student- tition in Divisions I and II sports in which the athlete tests positive during his or her season of com- Association conducts year-round drug testing and pri- petition (i.e., the remainder of contests in the current or to competition in all other sports in Divisions I, II season and contests in the subsequent season up to and III shall result in the student-athlete's ineligibility the period of time in which the student-athlete was for participation (i.e., practice and competition) in all declared ineligible during the previous year). The intercollegiate athletics (see also 3.2.4.6). Violations student-athlete shall remain ineligible for all regular- of this bylaw do not affect a' student-athlete's eligibility season and postseason competition during the time if the violation occurred due to an institutional admin- period ending one calendar year (i.e., 365 days) istrative error or oversight, and the student-athlete after the student-athlete's positive drug test, and until subsequently signs the form; however, the violation the student-athlete retests negative (in accordance with shall be considered an institutional violation per the testing methods authorized by the Executive 2.8.1.
Load more

Recommended publications
  • Properties and Units in Clinical Pharmacology and Toxicology
    Pure Appl. Chem., Vol. 72, No. 3, pp. 479–552, 2000. © 2000 IUPAC INTERNATIONAL FEDERATION OF CLINICAL CHEMISTRY AND LABORATORY MEDICINE SCIENTIFIC DIVISION COMMITTEE ON NOMENCLATURE, PROPERTIES, AND UNITS (C-NPU)# and INTERNATIONAL UNION OF PURE AND APPLIED CHEMISTRY CHEMISTRY AND HUMAN HEALTH DIVISION CLINICAL CHEMISTRY SECTION COMMISSION ON NOMENCLATURE, PROPERTIES, AND UNITS (C-NPU)§ PROPERTIES AND UNITS IN THE CLINICAL LABORATORY SCIENCES PART XII. PROPERTIES AND UNITS IN CLINICAL PHARMACOLOGY AND TOXICOLOGY (Technical Report) (IFCC–IUPAC 1999) Prepared for publication by HENRIK OLESEN1, DAVID COWAN2, RAFAEL DE LA TORRE3 , IVAN BRUUNSHUUS1, MORTEN ROHDE1, and DESMOND KENNY4 1Office of Laboratory Informatics, Copenhagen University Hospital (Rigshospitalet), Copenhagen, Denmark; 2Drug Control Centre, London University, King’s College, London, UK; 3IMIM, Dr. Aiguader 80, Barcelona, Spain; 4Dept. of Clinical Biochemistry, Our Lady’s Hospital for Sick Children, Crumlin, Dublin 12, Ireland #§The combined Memberships of the Committee and the Commission (C-NPU) during the preparation of this report (1994–1996) were as follows: Chairman: H. Olesen (Denmark, 1989–1995); D. Kenny (Ireland, 1996); Members: X. Fuentes-Arderiu (Spain, 1991–1997); J. G. Hill (Canada, 1987–1997); D. Kenny (Ireland, 1994–1997); H. Olesen (Denmark, 1985–1995); P. L. Storring (UK, 1989–1995); P. Soares de Araujo (Brazil, 1994–1997); R. Dybkær (Denmark, 1996–1997); C. McDonald (USA, 1996–1997). Please forward comments to: H. Olesen, Office of Laboratory Informatics 76-6-1, Copenhagen University Hospital (Rigshospitalet), 9 Blegdamsvej, DK-2100 Copenhagen, Denmark. E-mail: [email protected] Republication or reproduction of this report or its storage and/or dissemination by electronic means is permitted without the need for formal IUPAC permission on condition that an acknowledgment, with full reference to the source, along with use of the copyright symbol ©, the name IUPAC, and the year of publication, are prominently visible.
    [Show full text]
  • Prohibited Substances List
    Prohibited Substances List This is the Equine Prohibited Substances List that was voted in at the FEI General Assembly in November 2009 alongside the new Equine Anti-Doping and Controlled Medication Regulations(EADCMR). Neither the List nor the EADCM Regulations are in current usage. Both come into effect on 1 January 2010. The current list of FEI prohibited substances remains in effect until 31 December 2009 and can be found at Annex II Vet Regs (11th edition) Changes in this List : Shaded row means that either removed or allowed at certain limits only SUBSTANCE ACTIVITY Banned Substances 1 Acebutolol Beta blocker 2 Acefylline Bronchodilator 3 Acemetacin NSAID 4 Acenocoumarol Anticoagulant 5 Acetanilid Analgesic/anti-pyretic 6 Acetohexamide Pancreatic stimulant 7 Acetominophen (Paracetamol) Analgesic/anti-pyretic 8 Acetophenazine Antipsychotic 9 Acetylmorphine Narcotic 10 Adinazolam Anxiolytic 11 Adiphenine Anti-spasmodic 12 Adrafinil Stimulant 13 Adrenaline Stimulant 14 Adrenochrome Haemostatic 15 Alclofenac NSAID 16 Alcuronium Muscle relaxant 17 Aldosterone Hormone 18 Alfentanil Narcotic 19 Allopurinol Xanthine oxidase inhibitor (anti-hyperuricaemia) 20 Almotriptan 5 HT agonist (anti-migraine) 21 Alphadolone acetate Neurosteriod 22 Alphaprodine Opiod analgesic 23 Alpidem Anxiolytic 24 Alprazolam Anxiolytic 25 Alprenolol Beta blocker 26 Althesin IV anaesthetic 27 Althiazide Diuretic 28 Altrenogest (in males and gelidngs) Oestrus suppression 29 Alverine Antispasmodic 30 Amantadine Dopaminergic 31 Ambenonium Cholinesterase inhibition 32 Ambucetamide Antispasmodic 33 Amethocaine Local anaesthetic 34 Amfepramone Stimulant 35 Amfetaminil Stimulant 36 Amidephrine Vasoconstrictor 37 Amiloride Diuretic 1 Prohibited Substances List This is the Equine Prohibited Substances List that was voted in at the FEI General Assembly in November 2009 alongside the new Equine Anti-Doping and Controlled Medication Regulations(EADCMR).
    [Show full text]
  • Correspondence
    SEPT. 26, 1959 TO-DAY'S DRUGS MEDICAL JOURNAL 577 convulsions. The electroencephalogram changes can be reversed and the convulsions stopped by the intravenous administration of sodium thiopentone. Correspondence Although at irst it was thought that bemegride had a specific action in antagonizing the depressant effects of Because of heavy pressure on our space, correspondents are barbiturates on the central nervous system, this view is now asked to keep their letters short. no longer held. Bemegride is looked upon as a non- specific stimulant of the central nervous system and beneficial in treating cases of poisoning by various other Isaac Wolfson Foundation's Fund narcotics (other than barbiturates), such as primidone and glutethimide, as well as barbiturates. `SIR,-I would like to thank you for your leading Therapeutic uses of bemegride are as follows: article on the subject of the recent magnificent grant to (1) In the treatment of acute barbiturate poisoning. Here, in the Royal College of Physicians (Journal, September 12, addition to the usual general method of dealing with a comatose p. 416) and for giving space to a description of the patient, a 5% glucose saline intravenous infusion is given slowly, important activities of the Isaac Wolfson Foundation and 10 ml. of 0.5% solution of bemegride (50 mg.) is injected (p. 427). This grant is indeed a historic gift which my into the tubing leading to the intravenous cannula every three and Medicine are not to to five minutes. Some clinicians'precede each injection with 1 ml. College British likely forget. of a 1.5% solution of amiphenazole (15 mg.).
    [Show full text]
  • Federal Register / Vol. 60, No. 80 / Wednesday, April 26, 1995 / Notices DIX to the HTSUS—Continued
    20558 Federal Register / Vol. 60, No. 80 / Wednesday, April 26, 1995 / Notices DEPARMENT OF THE TREASURY Services, U.S. Customs Service, 1301 TABLE 1.ÐPHARMACEUTICAL APPEN- Constitution Avenue NW, Washington, DIX TO THE HTSUSÐContinued Customs Service D.C. 20229 at (202) 927±1060. CAS No. Pharmaceutical [T.D. 95±33] Dated: April 14, 1995. 52±78±8 ..................... NORETHANDROLONE. A. W. Tennant, 52±86±8 ..................... HALOPERIDOL. Pharmaceutical Tables 1 and 3 of the Director, Office of Laboratories and Scientific 52±88±0 ..................... ATROPINE METHONITRATE. HTSUS 52±90±4 ..................... CYSTEINE. Services. 53±03±2 ..................... PREDNISONE. 53±06±5 ..................... CORTISONE. AGENCY: Customs Service, Department TABLE 1.ÐPHARMACEUTICAL 53±10±1 ..................... HYDROXYDIONE SODIUM SUCCI- of the Treasury. NATE. APPENDIX TO THE HTSUS 53±16±7 ..................... ESTRONE. ACTION: Listing of the products found in 53±18±9 ..................... BIETASERPINE. Table 1 and Table 3 of the CAS No. Pharmaceutical 53±19±0 ..................... MITOTANE. 53±31±6 ..................... MEDIBAZINE. Pharmaceutical Appendix to the N/A ............................. ACTAGARDIN. 53±33±8 ..................... PARAMETHASONE. Harmonized Tariff Schedule of the N/A ............................. ARDACIN. 53±34±9 ..................... FLUPREDNISOLONE. N/A ............................. BICIROMAB. 53±39±4 ..................... OXANDROLONE. United States of America in Chemical N/A ............................. CELUCLORAL. 53±43±0
    [Show full text]
  • Appendix B Banned Drugs
    APPENDIX B BANNED DRUGS (This list complies with 2004-2005 NCAA Bylaw 31.2.3.1 Banned Drugs) A. Stimulants: amiphenazole amphetamine bemigride benzphetamine bromantan caffeine1 (guarana) chlorphentermine cocaine cropropamide crothetamide diethylpropion dimethylamphetamine doxapram ephedrine (ephedra, ma huang) ethamivan ethylamphetamine fencamfamine meclofenoxate methamphetamine methylene-dioxymethamphetamine [MDMA (ecstasy)] methylphenidate nikethamide pemoline pentetrazol phendimetrazine phenmetrazine phentermine phenylephrine phenylpropanolamine (ppa) picrotoxine pipradol prolintane strychnine synephrine (citrus aurantium, zhi shi, bitter orange) and related compounds Approved by Cabinet:1/31/05 Adopted by Board of Trustees:3/18/05 Page 12 of 15 B. Anabolic Agents: polythiazide anabolic steroids quinethazone androstenediol spironolactone androstenedione triamterene boldenone trichlormethiazide clostebol and related compounds dehydrochlormethyltestosterone dehydroepiandrosterone (DHEA) dihydrotestosterone (DHT) D. Street Drugs: dromostanolone heroin fluoxymesterone marijuana3 gestrinone THC mesterolone (tetrahydrocannabinol3 methandienone methenolone methyltestosterone nandrolone norandrostenediol norandrostenedione norethandrolone oxandrolone oxymesterone oxymetholone stanozolol testosterone2 tetrahydrogestrinone (THG) trenbolone and related compounds other anabolic agents clenbuterol C. Diuretics: acetazolamide bendroflumethiazide benzthiazide bumetanide chlorothiazide chlorthalidone ethacrynic acid flumethiazide furosemide hydrochlorothiazide
    [Show full text]
  • Pharmacology of Stimulants Prohibited by the World Anti-Doping Agency (WADA)
    British Journal of Pharmacology (2008) 154, 606–622 & 2008 Nature Publishing Group All rights reserved 0007– 1188/08 $30.00 www.brjpharmacol.org REVIEW Pharmacology of stimulants prohibited by the World Anti-Doping Agency (WADA) JR Docherty Department of Physiology, Royal College of Surgeons in Ireland, Dublin, Ireland This review examines the pharmacology of stimulants prohibited by the World Anti-Doping Agency (WADA). Stimulants that increase alertness/reduce fatigue or activate the cardiovascular system can include drugs like ephedrine available in many over- the-counter medicines. Others such as amphetamines, cocaine and hallucinogenic drugs, available on prescription or illegally, can modify mood. A total of 62 stimulants (61 chemical entities) are listed in the WADA List, prohibited in competition. Athletes may have stimulants in their body for one of three main reasons: inadvertent consumption in a propriety medicine; deliberate consumption for misuse as a recreational drug and deliberate consumption to enhance performance. The majority of stimulants on the list act on the monoaminergic systems: adrenergic (sympathetic, transmitter noradrenaline), dopaminergic (transmitter dopamine) and serotonergic (transmitter serotonin, 5-HT). Sympathomimetic describes agents, which mimic sympathetic responses, and dopaminomimetic and serotoninomimetic can be used to describe actions on the dopamine and serotonin systems. However, many agents act to mimic more than one of these monoamines, so that a collective term of monoaminomimetic may be useful. Monoaminomimietic actions of stimulants can include blockade of re-uptake of neurotransmitter, indirect release of neurotransmitter, direct activation of monoaminergic receptors. Many of the stimulants are amphetamines or amphetamine derivatives, including agents with abuse potential as recreational drugs.
    [Show full text]
  • A Abacavir Abacavirum Abakaviiri Abagovomab Abagovomabum
    A abacavir abacavirum abakaviiri abagovomab abagovomabum abagovomabi abamectin abamectinum abamektiini abametapir abametapirum abametapiiri abanoquil abanoquilum abanokiili abaperidone abaperidonum abaperidoni abarelix abarelixum abareliksi abatacept abataceptum abatasepti abciximab abciximabum absiksimabi abecarnil abecarnilum abekarniili abediterol abediterolum abediteroli abetimus abetimusum abetimuusi abexinostat abexinostatum abeksinostaatti abicipar pegol abiciparum pegolum abisipaaripegoli abiraterone abirateronum abirateroni abitesartan abitesartanum abitesartaani ablukast ablukastum ablukasti abrilumab abrilumabum abrilumabi abrineurin abrineurinum abrineuriini abunidazol abunidazolum abunidatsoli acadesine acadesinum akadesiini acamprosate acamprosatum akamprosaatti acarbose acarbosum akarboosi acebrochol acebrocholum asebrokoli aceburic acid acidum aceburicum asebuurihappo acebutolol acebutololum asebutololi acecainide acecainidum asekainidi acecarbromal acecarbromalum asekarbromaali aceclidine aceclidinum aseklidiini aceclofenac aceclofenacum aseklofenaakki acedapsone acedapsonum asedapsoni acediasulfone sodium acediasulfonum natricum asediasulfoninatrium acefluranol acefluranolum asefluranoli acefurtiamine acefurtiaminum asefurtiamiini acefylline clofibrol acefyllinum clofibrolum asefylliiniklofibroli acefylline piperazine acefyllinum piperazinum asefylliinipiperatsiini aceglatone aceglatonum aseglatoni aceglutamide aceglutamidum aseglutamidi acemannan acemannanum asemannaani acemetacin acemetacinum asemetasiini aceneuramic
    [Show full text]
  • Medicines Amendment Regulations 2018
    2018/179 Medicines Amendment Regulations 2018 Patsy Reddy, Governor-General Order in Council At Wellington this 24th day of September 2018 Present: Her Excellency the Governor-General in Council These regulations are made under section 105(1)(j) of the Medicines Act 1981— (a) on the advice and with the consent of the Executive Council; and (b) on the advice of the Minister of Health tendered after consultation with the organisations or bodies appearing to the Minister to be representative of per- sons likely to be substantially affected. Contents Page 1 Title 1 2 Commencement 2 3 Principal regulations 2 4 Schedule 1 replaced 2 5 Regulations revoked 2 Schedule 2 Schedule 1 replaced Regulations 1 Title These regulations are the Medicines Amendment Regulations 2018. 1 r 2 Medicines Amendment Regulations 2018 2018/179 2 Commencement These regulations come into force on the 28th day after the date of their notifi- cation in the Gazette. 3 Principal regulations These regulations amend the Medicines Regulations 1984 (the principal regu- lations). 4 Schedule 1 replaced Replace Schedule 1 with the Schedule 1 set out in the Schedule of these regula- tions. 5 Regulations revoked The Medicines Amendment Regulations (No 2) 2015 (LI 2015/180) are revoked. Schedule Schedule 1 replaced r 4 Schedule 1 Prescription, restricted, and pharmacy-only medicines r 3 Every reference to a medicine in this schedule applies whether the medicine is syn- thetic in origin or is from biological or mineral sources. Unless specific reference is made otherwise, every reference applies also to medicines that are— • preparations and admixtures containing any proportion of any substance listed in this schedule: • salts and esters of any substance listed in this schedule: • preparations or extracts of biological materials listed in this schedule: • salts or oxides of elements listed in this schedule.
    [Show full text]
  • 2021 Equine Prohibited Substances List
    2021 Equine Prohibited Substances List . Prohibited Substances include any other substance with a similar chemical structure or similar biological effect(s). Prohibited Substances that are identified as Specified Substances in the List below should not in any way be considered less important or less dangerous than other Prohibited Substances. Rather, they are simply substances which are more likely to have been ingested by Horses for a purpose other than the enhancement of sport performance, for example, through a contaminated food substance. LISTED AS SUBSTANCE ACTIVITY BANNED 1-androsterone Anabolic BANNED 3β-Hydroxy-5α-androstan-17-one Anabolic BANNED 4-chlorometatandienone Anabolic BANNED 5α-Androst-2-ene-17one Anabolic BANNED 5α-Androstane-3α, 17α-diol Anabolic BANNED 5α-Androstane-3α, 17β-diol Anabolic BANNED 5α-Androstane-3β, 17α-diol Anabolic BANNED 5α-Androstane-3β, 17β-diol Anabolic BANNED 5β-Androstane-3α, 17β-diol Anabolic BANNED 7α-Hydroxy-DHEA Anabolic BANNED 7β-Hydroxy-DHEA Anabolic BANNED 7-Keto-DHEA Anabolic CONTROLLED 17-Alpha-Hydroxy Progesterone Hormone FEMALES BANNED 17-Alpha-Hydroxy Progesterone Anabolic MALES BANNED 19-Norandrosterone Anabolic BANNED 19-Noretiocholanolone Anabolic BANNED 20-Hydroxyecdysone Anabolic BANNED Δ1-Testosterone Anabolic BANNED Acebutolol Beta blocker BANNED Acefylline Bronchodilator BANNED Acemetacin Non-steroidal anti-inflammatory drug BANNED Acenocoumarol Anticoagulant CONTROLLED Acepromazine Sedative BANNED Acetanilid Analgesic/antipyretic CONTROLLED Acetazolamide Carbonic Anhydrase Inhibitor BANNED Acetohexamide Pancreatic stimulant CONTROLLED Acetominophen (Paracetamol) Analgesic BANNED Acetophenazine Antipsychotic BANNED Acetophenetidin (Phenacetin) Analgesic BANNED Acetylmorphine Narcotic BANNED Adinazolam Anxiolytic BANNED Adiphenine Antispasmodic BANNED Adrafinil Stimulant 1 December 2020, Lausanne, Switzerland 2021 Equine Prohibited Substances List . Prohibited Substances include any other substance with a similar chemical structure or similar biological effect(s).
    [Show full text]
  • ATHLETICS STANDARD OPERATING PROCEDURES (SOP) Core Values Community, Integrity, Diversity, Scholarship and Outreach
    ATHLETICS STANDARD OPERATING PROCEDURES (SOP) Core Values Community, Integrity, Diversity, Scholarship and Outreach DELAWARE STATE UNIVERSITY 1 Table of Contents Administration Athletics Directory………………………………………………………………………8 Delaware State University (DSU) Mission and Vision Statement….……………….…11 Athletics Mission and Vision Statement ………………………..…………………….12 Organizational Chart……………………………………………………….………….13 Onboarding……….…………………………………………………...........................14 Out Processing Employees………………………………………………………….....14 Salaries (Athletics)………………………………………………………………….....15 Email Signature………………………………………………………………………..16 Leave/Vacation (Athletics)-DSU……………………………………………………...17 Benefits-Paystubs-W-2’s………………………………………………………………18 Outside Employment…………………………………………………………………..19 Game/Competition Contracts …………………………………………………………19 Budget and Finance Policies and Procedures Responsibility and Control…………………………………………………………….20 Budget…………………………………………………………………………………20 Annual Audit….…………………………………………………………………….....20 Team Travel …………………………………………………………………………...20 Individual Travel……………………………………………………………………….21 Petty Cash for Student Host during On-Campus Recruiting…………………………..22 Rights Holder Multiyear Agreement…………………………………………………...22 Scope of Services Rendered by Peak Sports…………………………………...22 Money received by Athletics…………………………………………………………..23 DSU Athletic Camps………………………………………………….………………..25 Receipt book procedures………….…………………………………………...25 Cash Handling Prior to deposit………………………………………………..25 Deposits………………………………………………………………………..25 Other Miscellaneous
    [Show full text]
  • Prohibited List 2021
    WORLD ANTI-DOPING CODE INTERNATIONAL STANDARD PROHIBITED LIST 2021 This List shall come into effect on 1 January 2021. TABLE OF CONTENTS Please note that the list of examples of medical conditions below is not inclusive. SUBSTANCES & METHODS PROHIBITED AT ALL TIMES S0 Non-approved substances ..................................................................................4 S1 Anabolic agents ...................................................................................................5 Some of these substance(s) may be found, without limitation, in medications used for the treatment of e.g. male hypogonadism. S2 Peptide hormones, growth factors, related substances, and mimetics ...........7 Some of these substance(s) may be found, without limitation, in medications used for the treatment of e.g. anaemia, male hypogonadism, growth hormone deficiency. S3 Beta-2 agonists ...................................................................................................9 Some of these substance(s) may be found, without limitation, in medications used for the treatment of e.g. asthma and other respiratory disorders. S4 Hormone and metabolic modulators ...............................................................10 Some of these substance(s) may be found, without limitation, in medications used for the treatment of e.g. breast cancer, diabetes, infertility (female), polycystic ovarian syndrome. S5 Diuretics and masking agents ..........................................................................12 Some of these substance(s) may
    [Show full text]
  • Poisons Standard February 2020
    POISONS STANDARD FEBRUARY 2020 I, Avi Rebera, as delegate of the Secretary to the Department of Health, make the following Poisons Standard. Dated 23 December 2019 Avi Rebera Assistant Secretary Regulatory Engagement and Planning Branch Health Products Regulation Group Department of Health Authorised Version F2020L00017 registered 10/01/2020 1. Name This instrument is the Poisons Standard February 2020. 2. New Poisons Standard This instrument consists of the Standard for the Uniform Scheduling of Medicines and Poisons No. 27 (the SUSMP 27), as set out in Schedule 2. 3. Commencement (1) Each provision of this instrument specified in column 1 of the table commences, or is taken to have commenced, in accordance with column 2 of the table. Any other statement in column 2 has effect according to its terms. Commencement information Column 1 Column 2 Column 3 Provisions Commencement Date/Details 1. The whole of this 1 February 2020. 1 February 2020 instrument Note: This table relates only to the provisions of this instrument as originally made. It will not be amended to deal with any later amendments of this instrument. (2) Any information in column 3 of the table is not part of this instrument. Information may be inserted in this column, or information in it may be edited, in any published version of this instrument. 4. Authority This instrument is made under paragraph 52D(2)(b) of the Therapeutic Goods Act 1989. 5. Repeals Each instrument that is specified in Schedule 1 to this instrument is repealed as set out in that Schedule. Authorised Version F2020L00017 registered 10/01/2020 Schedule 1—Repeals Note: See section 5.
    [Show full text]